AOD-9604 5mg Peptides
For researchers who value exactness, this vial delivers consistent peptide integrity with the disciplined quality your work requires.
Meet AOD-9604 from Well Elevation: a lyophilized peptide vial designed for controlled laboratory workflows. This unflavored, dry-powder format features the AOD-9604 peptide with a total content of 5mg, providing a reliable starting point for in vitro experiments, assay development, and analytical method validation.
- Each vial contains 5mg of AOD-9604, a focused peptide fragment investigated for stability, sequence fidelity, and solution behavior in controlled research settings.
The lyophilized format supports careful handling and measured reconstitution by qualified personnel. When prepared with suitable sterile diluent under aseptic technique, the material is intended to integrate into standard laboratory procedures with predictable performance. Researchers commonly evaluate solubility characteristics, compatibility with buffers, and response within target assay conditions to ensure consistent, reproducible outcomes.
Use in accordance with your laboratorys SOPs and quality systems. Many teams organize handling around minimal exposure to moisture, controlled light conditions, and temperature-stable storage to protect peptide integrity. Reconstitution parameters, diluents, and concentrations should be selected to match the requirements of your specific protocol. Avoid unnecessary temperature cycling and follow established documentation practices to support traceability and repeatability across runs.
Well Elevation prioritizes quality at every step. Lots are produced under controlled, cGMP-aligned procedures with rigorous documentation. Each batch is tested for identity and purity using appropriate analytical methods (e.g., HPLC/LC-MS), and packaged to maintain integrity through transit. Clear labeling, lot tracking, and transparent documentation support confident method development and audit readiness. As a USA-based research brand, we focus on consistency, traceability, and compliance so your team can work with clarity.
Research Use Only. Not for human consumption, medical, or veterinary use. For laboratory, in vitro, or investigational applications by qualified professionals only. Handle with appropriate PPE and follow all applicable regulations and institutional guidelines.
With an emphasis on precision manufacturing, careful handling, and verified composition, Well Elevation AOD-9604 5mg offers a dependable peptide option for modern research environments where quality is non-negotiable.
- Most orders ship within 24 hours and arrive within 3 to 5 days of leaving our warehouse.
- Shipping is free on orders of $99+ (except Hawaii and Alaska).
- All orders ship in discreet packaging via USPS Ground Advantage mail.
Delivery restrictions vary by state.
This Product Contains
Customer Reviews
There are no reviews yet. Be the first to write a review!
Frequently Asked Questions
What is AOD-9604?
AOD-9604 is a modified fragment of human growth hormone, commonly described as the 176-191 region. In research settings it is presented as a peptide of interest in lipid-metabolism studies, with a profile intended to differ from full-length growth hormone. It should be framed as a research compound only.
What is AOD-9604 typically studied for?
AOD-9604 is most often studied in relation to fat metabolism, lipolysis, and body-weight regulation in experimental models. It is usually distinguished from full HGH by the fact that researchers investigate it for metabolic effects without assuming the broader growth-promoting actions of native growth hormone.
What are GH peptides?
GH peptides — short for growth-hormone-related peptides — are a research category that includes two main subgroups. The first is growth-hormone-releasing hormone (GHRH) analogs, such as Sermorelin, Tesamorelin, and CJC-1295, which are studied for their interaction with the GHRH receptor. The second is growth hormone secretagogues, such as Ipamorelin, GHRP-2, GHRP-6, and Hexarelin, which are studied for their interaction with the ghrelin receptor (GHS-R1a).
Both subgroups are investigated in the research context of growth-hormone-axis biology. All GH peptide products from Well Elevation are lyophilized research compounds intended solely for in vitro laboratory investigation.
How do GH peptides differ from recombinant growth hormone?
Recombinant human growth hormone is the full 191-amino-acid human GH protein, produced via recombinant DNA technology. It is essentially identical to the endogenous hormone itself. GH peptides, by contrast, are much shorter sequences — typically on the order of a few to a few dozen amino acids — that do not act as GH themselves but rather engage upstream receptors (GHRH-R or GHS-R1a) involved in the GH signaling axis.
This makes the two categories mechanistically distinct. Recombinant GH is a replacement of the hormone itself, while GH peptides are research tools for studying the regulatory machinery that controls endogenous GH release.
What is the difference between GHRH analogs and GH secretagogues?
GHRH analogs are peptides modeled on the natural growth-hormone-releasing hormone sequence. They are studied for their ability to bind the GHRH receptor on the pituitary — the same receptor used by endogenous GHRH. Examples include Sermorelin (a GHRH 1-29 analog), Tesamorelin, and CJC-1295.
GH secretagogues are a structurally different class of peptides that act through the growth hormone secretagogue receptor (GHS-R1a), better known as the ghrelin receptor. Examples include Ipamorelin, GHRP-2, GHRP-6, and Hexarelin. The two classes engage different receptors and are therefore studied as distinct pharmacological families in research on GH signaling.
